Job Watch

Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)

Funding Opportunity RFA-AI-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.

Wellcome Sanger Institute: Statistical Geneticist

New Scientist - Bioinformatics - Mon, 2020-03-23 09:28
£37,398 to £44,798: Wellcome Sanger Institute: An exciting opportunity to participate in the enhancement of the Open Targets Genetics Portal through development of new functionality and features. Hinxton, Saffron Walden, Essex
Categories: Job Watch

EMBL: European Open Science Cloud Programme Manager

New Scientist - Bioinformatics - Mon, 2020-03-23 05:35
Competitive Salary: EMBL: European Open Science Cloud Programme Manager Locati Cambridge, Cambridgeshire, England
Categories: Job Watch

Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-20-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity is to stimulate new and innovative multidisciplinary research in the area of long acting therapeutics for HIV and HIV-associated tuberculosis (TB) and viral hepatitis B and C. Applications are sought that lead to new effective therapies for administration once per month or less frequently as oral, injectable, implantable, or transdermal products.

Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed)

Funding Opportunity RFA-DC-20-001 from the NIH Guide for Grants and Contracts. The over-arching goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical research and its implications in the areas of auditory and vestibular research. The complexity of auditory and vestibular biology processes provide our hearing and balance function. Interruption of these processes may occur from a variety of factors, including genetic, environmental and pathogenic agents, and often results in the loss of hearing and balance function. While loss or impairment of these functions are most often non-life-threatening, the disruption to quality of life is substantial. Since August of 2007, the National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) has supported a special topics course in auditory and vestibular biology. The two to three week course, Biology of the Inner Ear, has been held at the Marine Biological Laboratory in Woods Hole, MA, and has brought together outstanding faculty to provide hands-on instruction to participants. It is the continued intent of the NIDCD to foster the advancement of research methodologies and technologies to improve, hasten and implement new treatments for these disorders and impairments. It is based on this template of excellence that the NIDCD invites R25 applications for support of a special topics course in the auditory and vestibular sciences. The purpose of this five-year initiative is to support three courses to be offered each in years 2021, 2023, and 2025. This will allow for a sustained specialized topics course that provides lecture and hands-on research exposure to the auditory and vestibular sciences. The target audience envisioned for this course consists of advanced graduate students, post-doctoral fellows and established early stage research investigators.

Director of Bioinformatics - BioAutomation - Middleton, WI

Indeed.com - Bioinformatics - Fri, 2020-03-20 17:46
In molecular biology, genetics, bioinformatics, biostatistics, computational biology, or a related field and a minimum of 10 years’ experience in bioinformatics…
From BioAutomation - Fri, 20 Mar 2020 21:46:55 GMT - View all Middleton, WI jobs
Categories: Job Watch

Director of Bioinformatics - LGC Limited - Middleton, WI

Indeed.com - Bioinformatics - Fri, 2020-03-20 12:36
In molecular biology, genetics, bioinformatics, biostatistics, computational biology, or a related field and a minimum of 10 years’ experience in bioinformatics…
From LGC Limited - Fri, 20 Mar 2020 16:36:40 GMT - View all Middleton, WI jobs
Categories: Job Watch

Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)

Funding Opportunity PAR-20-143 from the NIH Guide for Grants and Contracts. Nearly 40,000 people in the U.S. die from firearm-related deaths each year, primarily from suicide (60%) or homicide (37%), and many more have experienced non-fatal firearm injuries, both intentional and nonintentional. The Joint Explanatory Statement accompanying the FY2020 Further Consolidated Appropriations Act (H.R. 1865) included funding for the NIH to conduct research on firearm injury and mortality prevention and recommended that NIH take a comprehensive approach to studying the underlying causes and evidence-based methods of prevention of firearm injury, including crime prevention. Within the legislative mandates and limitations of NIH funding (NOT-OD-20-068, NOT-OD-20-066), the NIH encourages research to improve understanding of the determinants of firearm injury, the identification of those at risk of firearm injury (including both victims and perpetrators), the development and evaluation of innovative interventions to prevent firearm injury and mortality, and the examination of approaches to improve the implementation of existing, evidence-based interventions to prevent firearm injury and mortality.

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Funding Opportunity PA-20-142 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to enhance predoctoral and postdoctoral research training, including short-term research training, and help ensure that a diverse and highly trained workforce is available to meet the needs of the Nations biomedical, behavioral, and clinical research agenda. Research training programs are expected to incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. Programs proposing only short-term predoctoral research training should not apply to this announcement, but rather to the Kirschstein-NRSA Short-Term Institutional Research Training Grant Program (T35) exclusively reserved for predoctoral, short-term research training (see PA-18-404). This Funding Opportunity Announcement (FOA) does not allow appointed trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

Notice of Special Interest: Alcohol and Cancer Control

Notice NOT-CA-20-034 from the NIH Guide for Grants and Contracts

Pages

Subscribe to Anil Jegga aggregator - Job Watch